Specialty Drug Spending in 2018 Highlights SPT Week in Review
Top news of the week from Specialty Pharmacy Times.
5. FDA Approves Two Fixed Dose HIV Treatments
New combination therapy gains approval for adult and pediatric patients with HIV-1. Read more.
4. Castration-Sensitive Prostate Cancer Drug Gets FDA Greenlight
FDA expands the indication of abiraterone acetate (Zytiga) to include more patients with prostate cancer. Read more.
3. Top 3 Legislative Priorities for Pharmacists
Direct and indirect remuneration fees remain a top concern for pharmacists in 2018. Read more.
2. Personalized Medicine Approvals Continued to Surge in 2017
Thirty-five percent of drug approvals in 2017 were personalized drugs. Read more.
1. Top 8 Specialty Drug Categories Driving Spending in 2018
Disease-modifying anti-rheumatic drugs are a major contributor to specialty drug spending. Read more.
